Cancer chemotherapy. II.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001215:Asparaginase / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001761:Bleomycin / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D004123:Dimethylamines / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005467:Floxuridine / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007093:Imidazoles / Q000627:therapeutic use; D015122:Mercaptopurine / Q000627:therapeutic use; D008937:Mitomycins / Q000627:therapeutic use; D008939:Mitotane / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy*; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D010885:Pipobroman / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D013308:Streptonigrin / Q000627:therapeutic use; D013311:Streptozocin / Q000627:therapeutic use; D013866:Thioguanine / Q000627:therapeutic use; D014226:Triazenes / Q000627:therapeutic use; D014227:Triazines / Q000627:therapeutic use; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D004123:Dimethylamines; D007093:Imidazoles; D008937:Mitomycins; D009607:Nitrosourea Compounds; D014226:Triazenes; D014227:Triazines; D005467:Floxuridine; D003561:Cytarabine; D001761:Bleomycin; D003609:Dactinomycin; D013308:Streptonigrin; D011344:Procarbazine; D014750:Vincristine; D014747:Vinblastine; D013311:Streptozocin; D010885:Pipobroman; D008939:Mitotane; D004317:Doxorubicin; D015122:Mercaptopurine; D001215:Asparaginase; D013866:Thioguanine; D001379:Azathioprine; D005472:Fluorouracil; D006918:Hydroxyurea; D003630:Daunorubicin